Abstracts

Filters

Clear Filters
All Days Sun, Sep 28 Mon, Sep 29 Tue, Sep 30 Wed, Oct 01

Tuesday, September 30

1:45 PM - 1:55 PM PT

328 - A Multicenter, Blinded, Intensity Modulated Proton Therapy Competitive Planning Study for Head and Neck Cancers: The Urgency for Guidelines and Standards
Speaker: Snider, James, MD - University of Maryland Medical Center, Baltimore, MD
1:45 PM - 1:55 PM PT

Discussant
Speaker: Breen, William, MD - Mayo Clinic Rochester, Rochester, Minnesota
1:45 PM - 1:55 PM PT

Discussant
Speaker: Henke, Lauren, MD, MS - University Hospitals/Case Western Reserve University, Cleveland, Ohio
2:30 PM - 2:40 PM PT

329 - Phase II Trial of Re-Priming Radiation Therapy for Relapsed/Refractory Non-Hodgkin Lymphoma Patients in Incomplete Response after Chimeric Antigen Receptor T-cell (CAR-T) Therapy
Speaker: Kumar, Kiran, MD, MBA - UT Southwestern Medical Center, Dallas, TX
2:30 PM - 2:40 PM PT

334 - Validation of a Poissonian LQ-Based Population TCP Model for Breast Cancer Radiotherapy
Speaker: Unterkirhers, Sergejs, DSc, PhD, MS, BS - Radiotherapy Hirslanden, Zurich, Zurich
2:30 PM - 2:40 PM PT

Decreasing the Dose of Consolidation Radiation Therapy in DLBCL/HGBL: A Phase II Trial by the International Lymphoma Radiation Oncology Group
Speaker: Kelsey, Christopher, MD, FASTRO - Duke University Medical Center, Durham, North Carolina
2:30 PM - 3:45 PM PT

Hem 2: New Protocols, New Paradigms: Clinical Trials Shaping the Future of Hematologic RT
Speaker: Brady, Jessica, MD, MB, ChB - Guys and St Thomas NHS Trust, London, City of Lo
2:30 PM - 3:45 PM PT

Hem 2: New Protocols, New Paradigms: Clinical Trials Shaping the Future of Hematologic RT
Speaker: Mohindra, Pranshu, MD, MMM - University Hospitals Seidman Cancer Center, Cleveland, OH, Cleveland, OH
2:30 PM - 3:45 PM PT

Radiation and Cancer Physics 7: AI-Driven Imaging and Predictive Modeling
Speaker: Sheng, Ke, PhD - University of California, San Francisco, San Francisco, CA
2:30 PM - 3:45 PM PT

Radiation and Cancer Physics 7: AI-Driven Imaging and Predictive Modeling
Speaker: Prior, Phillip, PhD - The Medical College of Wisconsin, Milwaukee, WI
2:40 PM - 2:50 PM PT

330 - Pembrolizumab and Involved Site Radiation Therapy Alone as an Alternative to Transplant in Patients with Localized Failure following Chemotherapy for Hodgkin Lymphoma: A Prospective Multicenter Phase
Speaker: Dreyfuss, Alexandra, MD, MS - Memorial Sloan Kettering Cancer Center, New York, NY
2:40 PM - 2:50 PM PT

335 - Predicting Voxel-Level Local Progression for Locally Advanced NSCLC following Chemoradiation Using Multi-Task Deep Learning
Speaker: Fu, Jie, PhD - University of Washington, Seattle, WA